Which blood biomarkers actually matter for longevity?

Short answer: there’s no single “longevity” blood test, but a set of reliably predictive biomarkers track the biggest drivers of lifespan and healthy aging — cardiovascular disease, metabolic disease, inflammation, organ function, and nutritional deficits. Below I list the most important blood biomarkers, why they matter, what to watch for, how often to test, and a few specific labs/services that can run them or give extra interpretation.

Top biomarkers to watch (what they say and why)

• Lipids and atherogenic markers

  • LDL‑C, non‑HDL‑C, triglycerides, HDL‑C — core CVD risk markers. High LDL/non‑HDL and triglycerides → higher atherosclerotic risk.
  • ApoB and LDL particle number (LDL‑P or NMR lipoprofile) — better predictors of atherosclerosis than LDL‑C alone.
  • Lp(a) — genetically determined independent risk factor for early atherosclerosis; test once in adulthood. Why: cardiovascular disease is the leading cause of death; these markers predict risk and guide treatment.

• Glucose metabolism

  • Fasting glucose, HbA1c, fasting insulin, (or OGTT if indicated), HOMA‑IR. Why: dysglycemia and insulin resistance drive diabetes, cardiovascular disease, dementia — major longevity determinants.

• Inflammation and immune activation

  • hs‑CRP (high‑sensitivity C‑reactive protein), IL‑6 (if available), fibrinogen, neutrophil:lymphocyte ratio. Why: chronic low‑grade inflammation (“inflammaging”) predicts multimorbidity and mortality.

• Kidney function

  • Serum creatinine/eGFR, cystatin C, urine albumin:creatinine ratio (ACR). Why: CKD raises mortality and accelerates other aging pathways.

• Cardiac injury/stress markers

  • NT‑proBNP (heart stress), high‑sensitivity troponin. Why: detect subclinical heart disease/risk even when other tests look OK.

• Liver function & metabolic health

  • ALT, AST, GGT, albumin, bilirubin. Why: fatty liver and liver dysfunction are linked to metabolic disease and mortality.

• Complete blood count (CBC) & related

  • Hemoglobin, hematocrit, white cell count, platelets, RDW (red cell distribution width). Why: anemia, elevated RDW, and abnormal WBC patterns associate with frailty and higher mortality.

• Micronutrients & related

  • 25‑OH vitamin D, vitamin B12, folate, iron studies/ferritin. Why: deficiencies cause frailty, cognitive problems, and increased disease risk — many are fixable.

• Hormones relevant to aging

  • Total and free testosterone (in men if indicated), estradiol (women as appropriate), SHBG, DHEA‑S, TSH/free T4 (thyroid). Why: hormone deficiencies or imbalances affect muscle, bone, metabolism, cognition and frailty.

• Growth factors and other aging markers (interpret with nuance)

  • IGF‑1 — associated with growth/cancer/aging pathways (U‑shaped relationships).
  • Homocysteine — elevated levels linked to CVD and cognitive decline.
  • Omega‑3 index — low index linked to higher cardiac risk. Why: these are informative but typically need contextual interpretation.

• Emerging/biological‑age tests (optional)

  • DNA methylation clocks (epigenetic age; e.g., GrimAge) and telomere length assays. Why: give an estimate of biological age and response to interventions — still evolving, useful for tracking but not diagnostic.

What to test and how often

• Core annual panel for most adults: fasting lipid panel (or advanced lipoprotein testing if family history), fasting glucose and/or HbA1c, hs‑CRP, CMP (kidney/liver/electrolytes), CBC, TSH, vitamin D, B12, ferritin.
• Add apoB/LDL‑P and Lp(a) if personal/family history of premature CVD — Lp(a) can be tested once.
• NT‑proBNP/hs‑troponin if heart disease risk or symptoms.
• Repeat frequency: annually for stable people; every 3–6 months if you’re treating an abnormality or making major lifestyle/medication changes.

Specific labs/services (why you might use them)

• LabCorp or Quest Diagnostics — broad coverage, clinical‑grade testing, widely used by clinicians; good for standard panels, Lp(a), apoB, NT‑proBNP, IL‑6 (available).
• InsideTracker — consumer‑facing panel + personalized interpretation and lifestyle recommendations geared toward performance/longevity; useful if you want actionable coaching with lab data.
• WellnessFX (or Vault by Wellness) — similar consumer service with clinician review and lifestyle guidance.
• Everlywell, LetsGetChecked — convenient at‑home collection kits for common panels (glucose, lipids, hormones); good for screening but limited for some specialized markers.
• OmegaQuant — specialty lab for the omega‑3 index (most clinical labs don’t run this).
• TruDiagnostic (or Chronomics) — DNA methylation clocks/epigenetic age testing if you want biological age tracking.
• TeloYears (if still available) or SpectraCell — telomere length assays (useful but more experimental/monitoring).
• Cleveland HeartLab and specialized CVD labs — for advanced inflammatory and atherothrombotic biomarkers if your clinician is managing complex CVD risk.

Interpreting results and next steps

• Targets vary by age, sex, and risk. For example, LDL goals are lower for people with known CVD or diabetes.
• Many biomarkers have U‑shaped relationships with outcomes (very low or very high can both be bad), so context matters.
• Abnormal tests should prompt discussion with a clinician before starting supplements/medications.
• Lifestyle modifications (exercise, Mediterranean/whole‑food diet, smoking cessation, sleep, stress reduction, weight control) move many of these markers in the right direction.

Caveats

• Some tests (epigenetic clocks, telomere length) are still emerging and should be used for tracking trends, not diagnostic certainty.
• Don’t over‑test without a plan — focus on biomarkers that change management.
• Always review abnormal results with a qualified clinician.

If you’d like, tell me:

• your age, sex, major medical history, and what you can test easily (lab access), and I’ll propose a specific baseline panel and testing frequency — and which services to use for each test.